🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for α-thalassemia

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia NCT05851105EARLY Phase 11 site📍 Nanning Shenzhen Hemogen · Tests: α-globin restored autologous hematopoietic stem cells A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemia Participants NCT05757245Phase 11 site📍 Nanning First Affiliated Hospital of Guangxi Medical University · Tests: GMCN-508A Drug Product A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) NCT07506863Phase 34 sites📍 Atlanta📍 New York📍 Philadelphia Agios Pharmaceuticals, Inc. · Tests: Mitapivat Matched Placebo, Mitapivat A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia NCT07517133Phase 35 sites📍 Palo Alto📍 Atlanta📍 New York Agios Pharmaceuticals, Inc. · Tests: Mitapivat, Placebo Matching Mitapivat
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy